Notwithstanding, we will briefly report data on miRNAs deregulated in HCC which were demonstrated to target PD-L1 or PD-1, either in HCC or in other cancer types, since it is conceivable that they might contribute to the deregulated expression of immune checkpoints in HCC as well. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.